CDHIC Wuhan Finalists Announce IPO Filing: Top Medical Innovation Projects Revealed
On August 18, with clear skies and cool, pleasant weather following the rain in Wuhan, the Wuhan Division Finals of the China Health and Medical Big Data Industry Innovation Competition (CDHIC) concluded successfully at the Optics Valley Smart Health Park. Twenty-five medical innovation projects competed fiercely throughout the day. Ultimately, Shijiazhuang Hanwei Medical Equipment Co., Ltd., Focal Healthcare Inc., and Beijing Zechuang Tiancheng Biopharmaceutical Technology Co., Ltd. secured first, second, and third place, respectively, in the Growth Star category; while Beijing Yizhun Intelligent Technology Co., Ltd., Hefei Kangling Medical Technology Co., Ltd., and Hangzhou Heyi Information Technology Co., Ltd. took first, second, and third place, respectively, in the Angel Star category.
Wuhan’s “Rising Stars” Each Have Their Unique Strengths: The First-Place Winner of the Growth Star Award Focuses on ECG Products and ECG Data, While the First-Place Winner of the Angel Star Award Boasts a Top-Tier Machine Learning Algorithm Team
# Rising Star Award – First PlaceShijiazhuang Hanwei Medical Equipment Co., Ltd., established in June 2010 and located in the West Zone Entrepreneurship Park of Shijiazhuang High-Tech Industrial Development Zone, is a manufacturer that leverages advanced smart healthcare technologies to provide ECG products and wearable devices to medical institutions and the general public. The company also operates as a third-party medical data processing service provider, specializing in ECG data acquisition, screening, and analysis. Recognized as a High-Tech Enterprise and a National Technology-Based Small and Medium-sized Enterprise, it holds four patents (including two invention patents), 19 computer software copyright registrations, and eight medical device product registration certificates. Operating within the “Internet + Healthcare” sector, the company’s core business focuses on the production and sale of 12-lead remote ambulatory ECG monitoring equipment, along with monitoring and early-warning services.
Growth Star Award – 1st Place: Shijiazhuang Hanwei Medical Equipment Co., Ltd.
Presenter: Zhang Lin, Vice President of Investment at CEC Health Industry Fund (first from the left)
"Angel Star" First Place: Beijing Yizhun Intelligent Technology Co., Ltd. is a company specializing in AI-assisted medical imaging diagnosis, boasting a top-tier machine learning algorithm team. The company's CEO, Lv Chenchong, graduated from Peking University and has many years of experience in medical device product management and sales at GE and Siemens, where he served as Regional Sales Director. The CTO, Ding Jia, also graduated from Peking University, has won multiple international AI healthcare competitions including LUNA16 and Kaggle, was the champion of the domestic round of the Asia-Pacific University Robot Competition, and previously worked at Alibaba. The company currently offers products such as a pulmonary nodule screening system and a breast cancer screening system.
Angel Star First Place: Beijing Yizhun Intelligent Technology Co., Ltd.
Award Presenter: Li Sirui, General Manager of the Strategic Development Department of Tasly Holding Group (far right)
Second Place: Rising Star – Focal Healthcare Inc. is a medical imaging equipment company with a vision to further improve prostate cancer care by developing a suite of guidance devices. The company has pioneered the world’s first navigation system for prostate cancer biopsy, which leverages MRI and ultrasound technologies to provide real-time biopsy targeting with MRI-level precision, significantly enhancing the accuracy and success rate of biopsy procedures. Its technology aims to substantially increase the accuracy of prostate cancer biopsies while greatly reducing the financial, workflow, and integration barriers associated with other fusion products. The company’s first-generation product line, comprising two models, is already being sold in Canada, the United States, and Hong Kong.
Runner-up for Rising Star: Focal Healthcare Inc
Presenter: Li Zhe (far right), Founder of Baichuanghui International Biotechnology (Wuhan) Co., Ltd.
Angel Star Runner-up: Hefei Kangling Medical Technology Co., Ltd. is a technology-driven company specializing in the production, sales, and service of intelligent medical devices. The company’s mission is to leverage core technologies such as acoustics and artificial intelligence to achieve valuable applications in the medical field and promote the development of human health and wellness. Committed to creating premium intelligent medical products, the company focuses deeply on the smart healthcare sector. Its current core product offerings include a series of intelligent medical stethoscopes.
Runner-up of the Angel Star Award: Hefei Kangling Medical Technology Co., Ltd.
Award Presenter: Yao Jun, Assistant to the President of Yida China (far left)
Third Place in the Rising Stars Category: Beijing Zechuang Tiancheng Biopharmaceutical Technology Co., Ltd.Founded in 2015, Beijing Zechuang Tiancheng Biopharmaceutical Technology Co., Ltd. brings together outstanding medical and technical talents from both China and abroad. Leveraging big data architecture and the innovative concept of “Internet + Clinical Research,” the company provides high-quality data technology services for clinical research. After successfully securing several key national projects under the 13th Five-Year Plan in the field of respiratory medicine, the company fully merged with Yikaihui, China’s largest scientific research and education platform. It has also established strategic partnerships with the Soong Ching Ling Foundation and the National Alliance for Prevention and Control of Respiratory Diseases at the Primary Care Level. Transitioning from a single business model focused on medical big data, it has evolved into a platform-based company integrating scientific research education, research data, and research services. Currently, it collaborates with 300 hospitals across China, serving over 200,000 clinicians and covering more than 100,000 patients with respiratory diseases.
3rd Place, Rising Star: Beijing Zechuang Tiancheng Biopharmaceutical Technology Co., Ltd.
Award Presenter: Liu Huiguang, CEO of VCBeat (far left)
Angel Star Third Place: Hangzhou Heyi Information Technology Co., Ltd. specializes in the development and application of intelligent medical information search platforms, providing e-commerce services for high-quality medical care and health products both domestically and internationally. It addresses the current prevalence of disorganized and fraudulent medical information in China’s healthcare sector, enabling people to access professional, trustworthy medical information and services more conveniently.
Angel Star, 3rd Place: Hangzhou Heyi Information Technology Co., Ltd.
Award Presenter: Li Yang, Investment Director at Puhua Capital (far left)
The “Emerging” projects in the Wuhan division span 11 sectors, with most at pre-Series A financing stages, demonstrating a strong demand for resource empowerment.
The 30 healthcare innovation projects shortlisted for the Wuhan division finals of the CDHIC have generally been in operation for a relatively short period, with most of their parent companies established in 2015, 2016, 2017, and 2018. Compared to other regional finals, the shortlisted projects in this division cover a broader range of fields—up to 11 categories—including healthcare informatics, clinical tools, medical devices, general wellness, tech-enabled healthcare, consumer healthcare, maternal and child health, biotechnology, rehabilitation and nursing, and primary care. Among these, projects in healthcare informatics and tech-enabled healthcare remain the dominant forces, accounting for 14% and 27% of the total shortlisted projects, respectively. In terms of financing stages, 91% of the projects shortlisted for the Wuhan division finals are at pre-Series A stages, indicating a stronger demand for resource empowerment compared to other regions.
Zhang Lin, Liu Lili, and Li Zhe delivered speeches, while Judge Panel Chair Li Sirui provided a summary, jointly looking forward to the “emerging” forces of medical innovation in Wuhan
Representatives from CEC Data and CEC Digital Finance welcomed the judges, guests, and participating project representatives present at the event. They expressed their gratitude to Optics Valley Smart Health Park, the co-organizer of the Wuhan division, for its strong support of this regional final. The representatives also provided a brief introduction to CEC Data, CEC Digital Finance, and the CEC Health Industry Fund, and summarized several landmark events in the field of medical innovation in 2018. She wished all participating projects to leverage their strengths and achieve outstanding results.
Vice President of Investment, CEC Health Industry Fund: Zhang Lin
Liu Lili, Director of the Commerce Bureau of the East Lake High-Tech Development Zone and Executive Deputy Director of the Modern Service Industry Park, introduced the development progress of Wuhan and the East Lake High-Tech Development Zone over the past two years. She expressed high expectations for Wuhan’s medical innovation initiatives and encouraged the projects shortlisted for this regional final to strive for excellence, advance to the national finals, and achieve success.
Director of the Commerce Bureau of East Lake High-Tech Development Zone and Executive Deputy Director of the Modern Service Industry Park: Liu LiStrength
Mr. Li Zhe, founder of Baichuanghui International Biotechnology (Wuhan) Co., Ltd., stated that it was a special occasion for the judges, guests, and project representatives to gather together. He expressed Baichuanghui’s honor in co-organizing this competition, provided a brief introduction to the company, and extended a warm invitation to all attendees to visit Wuhan and Baichuanghui often. He also wished all participating projects satisfactory results.
Founder of Baichuanghui International Biotechnology (Wuhan) Co., Ltd.: Li Zhe
Mr. Li Sirui, Co-Chair of the Jury Panel for the Wuhan Division and General Manager of the Strategic Development Department at Tasly Holding Group, provided detailed comments on the day’s project presentations. He stated that project pitches should be data-driven and clearly articulate their specific advantages in terms of products, technologies, and business models when compared with peers in the same industry and category, thereby demonstrating their true capabilities. He expressed his hope to see more high-quality medical innovation projects from Wuhan at the National Finals.
Li Sirui, Co-Chair of the Judges’ Panel for the Wuhan Division and General Manager of the Strategic Development Department at Tasly Holding Group
Group Photo of the Judges
To meet the needs of numerous medical innovation enterprises, registration for this year’s China Health and Medical Big Data Industry Innovation Competition will remain open. The finals of the Beijing Division (Traditional Chinese Medicine + TMT Special Session) will be held at Peking University Healthcare Innovation Valley on August 25. If you wish to register for the competition and compete for limited opportunities for empowerment by the national team, please click the link below to visit the official competition website or scan the QR code. We look forward to your participation!
Official Website:http://vcbeat.top/cdhic
Scan the QR Code to Register for the Competition
Optics Valley Smart Health Park
“Optics Valley Smart Health Park” is located within Wuhan Software New City. It covers a planned total area of nearly 2,000 mu, with a total gross floor area of 1.8 million square meters, an overall plot ratio of 1.5, and an overall greenery rate of 45%. Currently, 300,000 square meters have been completed and are scheduled for phased handover and occupancy within 2017.
Optics Valley Smart Health Park is positioned to focus on smart health industries, including bioinformatics, gene sequencing, medical big data, R&D and manufacturing of high-end medical devices, testing and inspection, health management, and precision medicine. It has already attracted leading innovative enterprises in the smart healthcare sector, such as Tianyi Group (Meinian Onehealth), Zhizhong Technology, Biomarker Technologies, Ronghui Digital Healthcare, and Future Group. Leveraging the industrial and innovation ecosystem advantages of Optics Valley Bio-city, as well as the aggregation capabilities of Wuhan Software New City in internet, big data, and software information technologies, the park will pursue differentiated development, integration, complementarity, and mutual promotion alongside existing parks within Optics Valley Bio-city. Upon completion in 2020, it aims to attract 100 benchmark and industry-leading companies, settle 1,000 talents in the smart health industry, achieve an annual output value exceeding RMB 20 billion, and reach an annual output value of RMB 50 billion by 2025, becoming a vital, competitive, and dynamic innovation platform and an internationally leading demonstration park within Optics Valley’s life and health industry.